semaglutide vs. mounjaro vs Ozempic βοΈπ§ͺ 1οΈβ£ Both Ozempic (semaglutide) and Mounjaro (tirzepatide) are injectable incretin-based therapies originally developed for type 2 diabetes and now widely used for medical weight management. They work by Mounjaro journey | π Confused
Description
While some may experience weight stability, others may observe a small amount of weight loss
Compared to other weight-loss platforms that primarily prescribe brand-name GLP-1s, MEDVi is more budget-friendly because it does not require a standalone membership fee
The effect of tirzepatide on energy expenditure appears negligible, therefore making the effect on energy intake the most impactful [284]

Skip if: you need oral or sublingual formats, or the lowest possible sticker price matters more than predictability

It is not licensed by the MHRA for weight management
The diabetes and weight loss drug semaglutide significantly reduced symptoms and improved quality of life in people with obesity and the most common form of heart failure in a clinical trial, potentially expanding the already wildly popular drugs use beyond diabetes and weight loss and offering a new treatment option where few are available
